Medication use patterns for osteoporosis: An assessment of guidelines, treatment rates, and quality improvement interventions

被引:75
|
作者
Solomon, DH
Morris, C
Cheng, HL
Cabral, D
Katz, JN
Finkelstein, JS
Avorn, J
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02115 USA
关键词
D O I
10.4065/80.2.194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To assess current osteoporosis treatment guidelines, studies of osteoporosis treatment, and interventions to improve osteoporosis treatment. METHODS: We searched the medical literature for articles published between January 1, 1992, and December 31, 2003, and assessed all relevant articles using a structured data abstraction process. Because of substantial heterogeneity in study design, no attempt was made to summarize the data using meta-analytic techniques. RESULTS: Seventy-six articles met criteria for inclusion. Eighteen practice guidelines were studied. Most guidelines were consistent in key treatment recommendations. Among 18 studies of treatment rates in patients who had fractures, the weighted average varied from 22% for nonhormonal treatment to 19% for calcium. We found slightly higher treatment rates for patients taking oral glucocorticoids or for those older than 65 years. There were no consistent correlates of which patients received treatment. Six studies that examined treatment frequencies after bone densitometry all found that patients with lower bone mineral density were more likely to receive treatment. Most of the 8 interventions designed to improve osteoporosis treatment showed improvement in treatment rates; however, only 3 were randomized, and these showed the smallest effects. CONCLUSIONS: Frequency of treatment of osteoporosis in at-risk populations is low. However, our assessment of the literature revealed no clear and consistent predictors of undertreatment. Few carefully controlled interventions have been reported.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 50 条
  • [1] A quality improvement project to increase treatment rates of osteoporosis in general practice
    Bolton, Patrick
    Seibel, Markus
    Moses, Daniel
    Moore, Michael
    Goodger, Brendan
    AUSTRALIAN HEALTH REVIEW, 2025, 49 (01)
  • [2] Systematic assessment of the quality of osteoporosis guidelines
    A Cranney
    L Waldegger
    ID Graham
    M Man-Son-Hing
    A Byszewski
    DS Ooi
    BMC Musculoskeletal Disorders, 3
  • [3] Systematic assessment of the quality of osteoporosis guidelines
    Cranney, A
    Waldegger, L
    Graham, ID
    Man-Son-Hing, M
    Byszewski, A
    Ooi, DS
    BMC MUSCULOSKELETAL DISORDERS, 2002, 3 (1) : 1 - 10
  • [4] Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS)
    A. Modi
    S. Sen
    J. D. Adachi
    S. Adami
    B. Cortet
    A. L. Cooper
    P. Geusens
    D. Mellström
    J. P. Weaver
    J. P. van den Bergh
    P. A. Keown
    S. Sajjan
    Osteoporosis International, 2017, 28 : 2867 - 2876
  • [5] Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS)
    Modi, A.
    Sen, S.
    Adachi, J. D.
    Adami, S.
    Cortet, B.
    Cooper, A. L.
    Geusens, P.
    Mellstrom, D.
    Weaver, J. P.
    van den Bergh, J. P.
    Keown, P. A.
    Sajjan, S.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 2867 - 2876
  • [6] Improvement of medication event interventions through use of an electronic database
    Merandi, Jenna
    Morvay, Shelly
    Lewe, Dorcas
    Stewart, Barb
    Catt, Char
    Chanthasene, Phillip P.
    McClead, Richard
    Kappeler, Karl
    Mirtallo, Jay M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (19) : 1708 - 1714
  • [7] USING PHARMACIST CLINICAL INTERVENTION DATA FOR QUALITY IMPROVEMENT OF MEDICATION USE AND PHYSICIAN ASSESSMENT
    PHILLIPS, MS
    WILLIAMS, DB
    MAY, JR
    JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT, 1994, 20 (10): : 569 - 576
  • [8] Trends and determinants of prescription medication use for treatment of osteoporosis
    Farley, Joel F.
    Blalock, Susan J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (13) : 1191 - 1201
  • [9] First update of the Lebanese guidelines for osteoporosis assessment and treatment
    El-Hajj Fuleihan, Ghada
    Baddoura, Rafic
    Awada, Hassane
    Arabi, Asma
    Okais, Jad
    JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (03) : 383 - 396
  • [10] Patterns of bone mineral density testingCurrent guidelines, testing rates, and interventions
    Charles A. Morris
    Danielle Cabral
    Hailu Cheng
    Jeffrey N. Katz
    Joel S. Finkelstein
    Jerry Avorn
    Daniel H. Solomon
    Journal of General Internal Medicine, 2004, 19 : 783 - 790